These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10434820)

  • 41. Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study.
    Mirakhur RK
    Eur J Anaesthesiol; 1987 Nov; 4(6):411-9. PubMed ID: 3446491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
    Martin-Flores M; Paré MD; Campoy L; Gleed RD
    Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neostigmine-induced prolonged neuromuscular blockade in a patient with atypical pseudocholinesterase.
    Ramirez JG; Sprung J; Keegan MT; Hall BA; Bourke DL
    J Clin Anesth; 2005 May; 17(3):221-4. PubMed ID: 15896593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Residual neuromuscular blockade].
    Fuchs-Buder T; Schmartz D
    Anaesthesist; 2017 Jun; 66(6):465-476. PubMed ID: 28573344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of neuromuscular blockade.
    Bevan DR; Donati F; Kopman AF
    Anesthesiology; 1992 Oct; 77(4):785-805. PubMed ID: 1416176
    [No Abstract]   [Full Text] [Related]  

  • 48. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
    Paech MJ; Kaye R; Baber C; Nathan EA
    Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers: a double-blind, placebo-controlled, randomised volunteer study.
    Kent NB; Liang SS; Phillips S; Smith NA; Khandkar C; Eikermann M; Stewart PA
    Anaesthesia; 2018 Sep; 73(9):1079-1089. PubMed ID: 30132821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neostigmine for reversal of neuromuscular block in paediatric patients.
    Yang L; Yang D; Li Q; Zuo Y; Lu D
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010110. PubMed ID: 24793636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.
    Thilen SR; Ng IC; Cain KC; Treggiari MM; Bhananker SM
    Br J Anaesth; 2018 Aug; 121(2):367-377. PubMed ID: 30032875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Some actions of Org NC 45 and of edrophonium in the anaesthetized cat and in man.
    Baird WL; Bowman WC; Kerr WJ
    Br J Anaesth; 1982 Apr; 54(4):375-85. PubMed ID: 6121569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
    Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
    Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications.
    Rudolph MI; Chitilian HV; Ng PY; Timm FP; Agarwala AV; Doney AB; Ramachandran SK; Houle TT; Eikermann M
    Anaesthesia; 2018 Sep; 73(9):1067-1078. PubMed ID: 29974459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuncts to caudal blockade in children.
    Mahajan R; Batra YK; Kumar S
    Br J Anaesth; 2006 Mar; 96(3):401-2; author reply 402. PubMed ID: 16526100
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of hypothermia on the in vitro potencies of neuromuscular blocking agents and on their antagonism by neostigmine.
    Aziz L; Ono K; Ohta Y; Morita K; Hirakawa M
    Br J Anaesth; 1994 Nov; 73(5):662-6. PubMed ID: 7826797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of intrathecal neostigmine as an adjunct to other spinal medications in perioperative and peripartum analgesia: a meta-analysis.
    Ho KM; Ismail H; Lee KC; Branch R
    Anaesth Intensive Care; 2005 Feb; 33(1):41-53. PubMed ID: 15957690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
    Lessard MR; Trépanier CA; Rouillard JF
    Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
    Wali FA
    Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.